Multiple system atrophy (MSA) is a neurodegenerative disorder with limited treatment options. However, recent research has yielded potential insights into new therapeutic approaches. Current focus centers on addressing the underlying causes of MSA. One avenue under investigation involves drug-based interventions to regulate the activity of specifi